Announcement

Collapse
No announcement yet.

Immun Inflamm Dis . Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Immun Inflamm Dis . Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection


    Immun Inflamm Dis


    . 2022 Dec;10(12):e733.
    doi: 10.1002/iid3.733.
    Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection


    Yan Wu 1 , Yiyin Long 2 , Feng Wang 3 , Wei Liu 4 , Yuliang Wang 2



    Affiliations

    Abstract

    Introduction: Nowadays, emerging SARS-CoV-2 Omicron, the novel highly mutated VOC, has quickly spread as the dominant variant in over 190 countries worldwide through the first part of 2022, which is influencing the infectivity, transmissibility, pathogenicity, and severity of COVID-19 pandemic. Additionally, clinical cases and experimental studies have reported that Omicron variant likely leads to weakened immune protection elicited by infection, antibody therapies, and vaccines. The new wave, from late February, 2022, was escalated abruptly by higher levels of transmission of Omicron BA.2 sublineage in China.
    Methods and results: Following a systematic database search, this review summarizes the salient features of Omicron sublineages, and their impact on transmissibility, disease severity as well as the efficacy of the available vaccines and treatment against the Omicron.
    Conclusion: We hope this study will provide a scientific reference for alleviating the burden of COVID-19.

    Keywords: Omicron; mutations; severe acute respiratory syndrome coronavirus 2; transmissibility; vaccination.

Working...
X